What oral antibiotic regimen is recommended for an adult with eyelid and eyebrow cellulitis after skin trauma (e.g., shaving), assuming no pregnancy, no tetracycline allergy, and no β‑lactam allergy?

Oral Antibiotic Treatment for Eyelid and Eyebrow Cellulitis After Shaving Trauma

For an adult with eyelid and eyebrow cellulitis following shaving trauma, prescribe cephalexin 500 mg orally every 6 hours for 5 days, or alternatively dicloxacillin 250–500 mg orally every 6 hours for 5 days. These beta-lactam agents provide optimal coverage against the primary pathogens—beta-hemolytic streptococci (especially Streptococcus pyogenes) and methicillin-sensitive Staphylococcus aureus—that cause typical facial cellulitis. 1, 2

First-Line Beta-Lactam Monotherapy

• Beta-lactam monotherapy achieves approximately 96% clinical success in typical non-purulent cellulitis because the vast majority of cases are caused by streptococci and methicillin-sensitive staphylococci. 1
• Cephalexin 500 mg every 6 hours is the preferred first-generation cephalosporin, offering excellent activity against both S. pyogenes and methicillin-susceptible S. aureus. 1, 2
• Dicloxacillin 250–500 mg every 6 hours is an equally effective penicillinase-resistant penicillin alternative with comparable streptococcal and staphylococcal coverage. 1, 2
• Amoxicillin 500 mg three times daily provides adequate streptococcal coverage and represents another acceptable first-line option. 1

Treatment Duration

• Treat for exactly 5 days if clinical improvement occurs (reduced warmth, tenderness, and erythema; absence of fever); extend the course only if these signs have not improved within this timeframe. 1
• High-quality randomized controlled trial evidence demonstrates that 5-day courses are as effective as 10-day courses for uncomplicated cellulitis, with 98% clinical resolution at 14 days and no relapses by 28 days. 1
• Traditional 7–14-day regimens are unnecessary for uncomplicated cases and promote antimicrobial resistance without improving outcomes. 1

When MRSA Coverage Is NOT Needed

• Routine MRSA-active antibiotics are unnecessary for typical facial cellulitis after shaving trauma because MRSA is an uncommon cause of non-purulent cellulitis even in high-prevalence settings. 1, 2
• The shaving trauma itself does not constitute "penetrating trauma" in the guideline sense (which refers to deep puncture wounds, injection drug use, or surgical procedures), so it does not trigger the need for empiric MRSA coverage. 1

Indications for Adding MRSA Coverage

Add MRSA-active therapy only when any of the following specific risk factors are present: 1, 2

• Visible purulent drainage or exudate at the infection site (not present in typical non-purulent cellulitis)
• Penetrating trauma beyond superficial shaving (e.g., deep laceration, retained foreign body)
• Known MRSA colonization or prior documented MRSA infection
• Systemic inflammatory response syndrome (fever >38°C, heart rate >90 bpm, respiratory rate >24 breaths/min)
• Failure to respond to beta-lactam therapy after 48–72 hours of appropriate treatment

MRSA-Active Regimens (If Indicated)

If any of the above risk factors are present, use one of the following regimens: 1, 2

• Clindamycin 300–450 mg orally every 6 hours provides single-agent coverage for both streptococci and MRSA, eliminating the need for combination therapy; use only if local MRSA clindamycin resistance is <10%. 1, 3
• Trimethoprim-sulfamethoxazole 1–2 double-strength tablets twice daily PLUS cephalexin 500 mg every 6 hours ensures dual coverage, as TMP-SMX lacks reliable streptococcal activity and must be combined with a beta-lactam. 1
• Doxycycline 100 mg orally twice daily PLUS a beta-lactam (cephalexin or amoxicillin) is another combination option; doxycycline alone is inadequate because it does not reliably cover beta-hemolytic streptococci. 1

Penicillin Allergy Management

• For non-immediate (mild) penicillin allergy (e.g., maculopapular rash), cephalexin remains acceptable because cross-reactivity between penicillins and first-generation cephalosporins is only 2–4%. 1
• For true penicillin allergy with immediate hypersensitivity, prescribe clindamycin 300–450 mg every 6 hours (if local MRSA clindamycin resistance <10%) as single-agent therapy covering both streptococci and staphylococci. 1, 2, 3

Hospitalization Criteria

Admit patients with eyelid/eyebrow cellulitis if any of the following are present: 1, 2

• Systemic inflammatory response syndrome (fever, tachycardia, hypotension, altered mental status)
• Signs of orbital involvement (proptosis, ophthalmoplegia, vision changes, severe periorbital edema)
• Concern for deeper infection (severe pain out of proportion to exam, rapid progression, skin anesthesia)
• Severe immunocompromise or neutropenia
• Failure of outpatient therapy after 24–48 hours

Inpatient IV Therapy (If Hospitalization Required)

• Cefazolin 1–2 g IV every 8 hours is the preferred IV beta-lactam for uncomplicated cellulitis requiring hospitalization. 1
• For severe cellulitis with systemic toxicity or suspected necrotizing infection, use vancomycin 15–20 mg/kg IV every 8–12 hours PLUS piperacillin-tazobactam 3.375–4.5 g IV every 6 hours. 1

Essential Adjunctive Measures

• Elevate the head to promote gravity drainage of periorbital edema and inflammatory substances, which hastens clinical improvement. 1, 2
• Avoid further shaving trauma to the affected area until the infection has completely resolved. 1
• Reassess within 24–48 hours to confirm clinical response; oral regimens have reported treatment-failure rates of approximately 21% if no improvement is observed. 1

Critical Pitfalls to Avoid

• Do not add MRSA coverage reflexively for typical post-shaving facial cellulitis without the specific risk factors outlined above, as this overtreats the vast majority of cases and promotes resistance. 1, 2
• Do not use doxycycline or TMP-SMX as monotherapy for typical cellulitis, as they lack reliable activity against beta-hemolytic streptococci, the predominant pathogens. 1
• Do not automatically extend therapy to 7–10 days based solely on residual erythema; extend only if warmth, tenderness, or erythema have not improved after the initial 5-day course. 1
• Do not delay ophthalmology consultation if any signs of orbital involvement develop, as this represents a vision-threatening emergency requiring urgent imaging and possible surgical intervention. 1, 2

Monitoring and Follow-Up

• If no improvement after 48–72 hours of appropriate therapy, consider resistant organisms (MRSA), undrained abscess, deeper infection (orbital cellulitis, preseptal abscess), or alternative diagnoses (allergic contact dermatitis, angioedema). 1
• Blood cultures are unnecessary for typical uncomplicated facial cellulitis, as they are positive in only ~5% of cases and do not alter management. 1